BrightSpring Health raises 2025 guidance as Q3 revenue jumps 28%

LOUISVILLE - BrightSpring Health Services, Inc. (NASDAQ:BTSG), a $6.1 billion market cap healthcare provider currently trading near its 52-week high, reported preliminary third-quarter revenue of approximately $3.33 billion, up 28.2% from the same period last year, and raised its full-year guidance. According to InvestingPro analysis, the company’s stock has delivered an impressive 83% return over the past year.

The healthcare provider, which specializes in home and community-based health services and maintains a "GREAT" overall financial health score according to InvestingPro, posted preliminary net income of $37.5 million for the quarter ended September 30, compared to a net loss of $25.7 million in the third quarter of 2024.

Adjusted EBITDA increased 37.2% to approximately $160 million from $117 million in the year-ago period, according to the preliminary results released Monday.

BrightSpring’s Pharmacy Solutions segment led growth with revenue rising 31% to $2.97 billion, while Provider Services revenue increased 9% to $367 million.

Based on the strong performance, the company raised its full-year 2025 revenue guidance to between $12.4 billion and $12.7 billion, representing growth of 23.1% to 26.1% compared to 2024. Adjusted EBITDA is now expected to reach $605 million to $615 million, up 31.5% to 33.7% from the previous year.

"These third quarter 2025 results are preliminary and subject to the finalization of the Company’s regular financial and accounting procedures," BrightSpring noted in its press release.

The company’s planned divestiture of its Community Living business to Sevita, announced in January, is expected to close in early first quarter of 2026.

BrightSpring will announce its complete third-quarter results on October 28 and host a conference call the same day. The company’s leverage ratio stood at approximately 3.31x as of September 30, according to calculations under its credit agreements.

In other recent news, BrightSpring Health Services reported a 29% year-over-year increase in total revenue for the second quarter of 2025, reaching $3.1 billion. The company’s pharmacy solutions division played a significant role in driving this growth. Additionally, BrightSpring’s adjusted earnings per share rose to $0.22. In other developments, certain stockholders of BrightSpring, including an affiliate of Kohlberg Kravis Roberts & Co. L.P. and some members of its management team, announced plans to sell 15 million shares in a secondary offering. BrightSpring will not receive any proceeds from this sale. These recent developments reflect the company’s ongoing financial activities and shareholder decisions.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.